Stock info Hikma Pharmaceuticals | Filter Basic-Info
Stock: Hikma Pharmaceuticals
| Last Price | 1774.00 | Max Price | 2205.00 |
| Min Price | 1723.50 | 1 Year return | 14.30 |
| Sector | Health Care | Subsector | Pharmaceuticals |
Contact info:Street: 13 Hanover SquareZip Code: W1S 1HWCity: LondonCountry: Great BritainWebsite: http://www.hikma.com/
Sector Review Hikma Pharmaceuticals
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 2,203 | 615,634 | 0.36 % |
| 2020 | 2,341 | 638,070 | 0.37 % |
| 2021 | 2,553 | 727,968 | 0.35 % |
| 2022 | 2,517 | 787,273 | 0.32 % |
| 2023 | 0 | 0 | 0.00 % |
Advice Hikma Pharmaceuticals
No Records Found
News Hikma Pharmaceuticals
No Records Found
Annual reports Hikma Pharmaceuticals
No Records Found
Profile Hikma Pharmaceuticals
Hikma Pharmaceuticals
/ HIKlThe past year was a good year for Hikma Pharmaceuticals investors
The stock lost over the past 12 months at around 19 percent. Over the past 5 years Hikma Pharmaceuticals' stock lost at around 0 percent in value.
The headquarter of Hikma Pharmaceuticals is based in London. Hikma Pharmaceuticals's core business is the pharmaceutical sector. Over the past 10 years the global pharmaceutical companies gained around 75 percent. As from 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.
The English company didn't pay out any dividends (in the past 5 years).
Hikma Pharmaceuticals financed with a quite low debt position
At the end of 2015 the pharmaceutical company's balance sheet equaled 0 million GBp. At the end of 2015 the total debt positon equaled 0 million GBp. This is around percent of the total balance sheet.
All the company's financial reports are available here. More information about Hikma Pharmaceuticals can be found it's website. .
Results Hikma Pharmaceuticals
| Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Revenue |
1,440
|
1,950
|
1,936
|
2,076
|
2,203
|
2,341
|
| Costs |
1,188
|
1,795
|
2,779
|
1,794
|
1,717
|
1,910
|
| Profit |
252
|
155
|
-843
|
282
|
486
|
431
|
| Margin of profit |
17.50
|
7.95
|
-43.54
|
13.58
|
22.06
|
18.41
|
| ROI |
18.85
|
6.47
|
-55.68
|
16.74
|
22.96
|
20.19
|
Balance Hikma Pharmaceuticals
| Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Equity |
1,337
|
2,396
|
1,514
|
1,685
|
2,117
|
2,135
|
| Debt |
1,260
|
1,967
|
1,874
|
1,812
|
1,813
|
2,000
|
| Total assets |
2,597
|
4,363
|
3,388
|
3,497
|
3,930
|
4,135
|
| Solvency |
51.48
|
54.92
|
44.69
|
48.18
|
53.87
|
51.63
|
| Cash |
553
|
155
|
227
|
276
|
465
|
347
|
| Cashflow |
366
|
293
|
443
|
430
|
472
|
464
|
| Employees |
0
|
0
|
0
|
0
|
0
|
|
| Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow / Debt |
0.29
|
0.15
|
0.24
|
0.24
|
0.26
|
0.23
|
Details Hikma Pharmaceuticals
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
2301.00
|
1893.00
|
1134.00
|
1716.00
|
1991.00
|
| Eps |
0.66
|
-3.51
|
1.17
|
2.00
|
1.81
|
| Price/earnings-ratio |
3486.36
|
-539.32
|
969.23
|
858.00
|
980.11
|
| Dividend |
0.33
|
0.34
|
0.38
|
0.47
|
0.51
|
| Dividend % |
0.01 %
|
0.02 %
|
0.03 %
|
0.03 %
|
0.03 %
|
| Payout % |
0.50
|
-0.10
|
0.32
|
0.23
|
0.28
|
| Book value |
9.94
|
6.29
|
6.98
|
8.74
|
9.26
|
| Market to book |
0.0
|
0.0
|
0.01
|
0.01
|
0.01
|
| Cashflow per stock |
1.22
|
1.84
|
1.78
|
1.95
|
2.01
|
| Stocks |
241
|
241
|
241
|
242
|
230
|
| Market Cap |
554.541.00
|
455.605.14
|
273.809.97
|
415.819.40
|
408.832.49
|
Dividend Hikma Pharmaceuticals
Price info Hikma Pharmaceuticals
|
Date
|
Price
|
|---|---|
|
22 Apr 2024
|
1774.00
|
|
18 Apr 2024
|
1774.00
|
|
17 Apr 2024
|
1786.00
|
|
09 Apr 2024
|
1817.00
|
|
05 Apr 2024
|
1871.00
|
|
03 Apr 2024
|
1880.00
|
|
30 Mar 2024
|
1918.50
|
|
22 Mar 2024
|
1873.50
|
|
18 Mar 2024
|
1883.00
|
|
15 Mar 2024
|
1865.00
|
|
12 Mar 2024
|
1918.00
|
|
11 Mar 2024
|
1855.50
|
|
09 Mar 2024
|
1855.50
|
|
07 Mar 2024
|
1841.00
|
|
01 Mar 2024
|
1967.00
|
|
29 Feb 2024
|
1939.50
|
|
27 Feb 2024
|
1994.00
|
|
22 Feb 2024
|
1997.50
|
|
21 Feb 2024
|
1985.00
|
|
20 Feb 2024
|
1987.50
|
|
15 Feb 2024
|
1965.00
|
|
14 Feb 2024
|
1960.00
|
|
13 Feb 2024
|
1959.50
|
|
09 Feb 2024
|
1930.00
|
|
08 Feb 2024
|
1930.00
|
|
07 Feb 2024
|
1920.50
|
|
06 Feb 2024
|
1881.50
|
|
05 Feb 2024
|
1877.00
|
|
01 Feb 2024
|
1931.50
|
|
31 Jan 2024
|
1931.50
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
